Novo Nordisk AS (HAM:NOVA)
€ 41.8 -0.20 (-0.48%) Market Cap: 185.04 Bil Enterprise Value: 201.74 Bil PE Ratio: 11.60 PB Ratio: 6.95 GF Score: 81/100

Q3 2021 Novo Nordisk A/S Earnings Presentation (London-Based Investors) Transcript

Nov 04, 2021 / 01:15PM GMT

Nov 04, 2021 / 01:15PM GMT
Presentation (London-Based Investors)
Nov 04, 2021 / 01:15PM GMT

=====================
Corporate Participants
=====================
* Camilla Sylvest
Novo Nordisk A/S - Executive VP, Head of Commercial Strategy & Corporate Affairs and Member of the Management Board
* Karsten Munk Knudsen
Novo Nordisk A/S - Executive VP, CFO & Member of the Management Board
* Martin Holst Lange
Novo Nordisk A/S - Executive VP, Head of Development & Member of the Management Board

=====================
Conference Call Participants
=====================
* Jo Walton
Crédit Suisse AG, Research Division - MD
* Keyur Parekh
Goldman Sachs Group, Inc., Research Division - Equity Analyst
* Michael Leuchten
UBS Investment Bank, Research Division - Co-Head of Pharmaceuticals Research of Equity Research
* Peter Verdult
Citigroup Inc. Exchange Research - Research Analyst
* Peter James Welford
Jefferies LLC, Research Division - Senior Equity Analyst & European Pharmaceuticals

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot